JP2005508604A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005508604A5 JP2005508604A5 JP2002571827A JP2002571827A JP2005508604A5 JP 2005508604 A5 JP2005508604 A5 JP 2005508604A5 JP 2002571827 A JP2002571827 A JP 2002571827A JP 2002571827 A JP2002571827 A JP 2002571827A JP 2005508604 A5 JP2005508604 A5 JP 2005508604A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- nucleic acid
- amino acid
- group
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 37
- 150000007523 nucleic acids Chemical group 0.000 claims 36
- 229920001184 polypeptide Polymers 0.000 claims 36
- 102000004196 processed proteins & peptides Human genes 0.000 claims 36
- 108020004707 nucleic acids Proteins 0.000 claims 30
- 102000039446 nucleic acids Human genes 0.000 claims 30
- 239000002773 nucleotide Substances 0.000 claims 20
- 125000003729 nucleotide group Chemical group 0.000 claims 20
- 238000000034 method Methods 0.000 claims 17
- 239000000523 sample Substances 0.000 claims 15
- 125000003275 alpha amino acid group Chemical group 0.000 claims 12
- 150000001413 amino acids Chemical class 0.000 claims 12
- 201000010099 disease Diseases 0.000 claims 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 10
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 6
- 230000003902 lesion Effects 0.000 claims 6
- 125000000539 amino acid group Chemical group 0.000 claims 5
- 239000013068 control sample Substances 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 230000000295 complement effect Effects 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 230000000694 effects Effects 0.000 claims 3
- 239000012634 fragment Substances 0.000 claims 3
- 239000000126 substance Substances 0.000 claims 3
- 230000001225 therapeutic effect Effects 0.000 claims 3
- 239000003937 drug carrier Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 108091033319 polynucleotide Proteins 0.000 claims 2
- 102000040430 polynucleotide Human genes 0.000 claims 2
- 239000002157 polynucleotide Substances 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 208000011580 syndromic disease Diseases 0.000 claims 2
- 108091026890 Coding region Proteins 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 238000010494 dissociation reaction Methods 0.000 claims 1
- 230000005593 dissociations Effects 0.000 claims 1
- 239000003550 marker Substances 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
Applications Claiming Priority (64)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27428101P | 2001-03-08 | 2001-03-08 | |
US27410101P | 2001-03-08 | 2001-03-08 | |
US27419401P | 2001-03-08 | 2001-03-08 | |
US27432201P | 2001-03-08 | 2001-03-08 | |
US27484901P | 2001-03-09 | 2001-03-09 | |
US27523501P | 2001-03-12 | 2001-03-12 | |
US27560101P | 2001-03-13 | 2001-03-13 | |
US27557801P | 2001-03-13 | 2001-03-13 | |
US27557901P | 2001-03-13 | 2001-03-13 | |
US27600001P | 2001-03-14 | 2001-03-14 | |
US27677601P | 2001-03-16 | 2001-03-16 | |
US27699401P | 2001-03-19 | 2001-03-19 | |
US27732701P | 2001-03-20 | 2001-03-20 | |
US27733801P | 2001-03-20 | 2001-03-20 | |
US27723901P | 2001-03-20 | 2001-03-20 | |
US27732101P | 2001-03-20 | 2001-03-20 | |
US27779101P | 2001-03-21 | 2001-03-21 | |
US27783301P | 2001-03-22 | 2001-03-22 | |
US27815201P | 2001-03-23 | 2001-03-23 | |
US27889401P | 2001-03-26 | 2001-03-26 | |
US27903601P | 2001-03-27 | 2001-03-27 | |
US27899901P | 2001-03-27 | 2001-03-27 | |
US27934401P | 2001-03-28 | 2001-03-28 | |
US27999501P | 2001-03-30 | 2001-03-30 | |
US28023301P | 2001-03-30 | 2001-03-30 | |
US28080201P | 2001-04-02 | 2001-04-02 | |
US28090001P | 2001-04-02 | 2001-04-02 | |
US28082201P | 2001-04-02 | 2001-04-02 | |
US28119401A | 2001-04-04 | 2001-04-04 | |
US28367501P | 2001-04-13 | 2001-04-13 | |
US28742401P | 2001-04-30 | 2001-04-30 | |
US28806601P | 2001-05-02 | 2001-05-02 | |
US28834201P | 2001-05-03 | 2001-05-03 | |
US28852801P | 2001-05-03 | 2001-05-03 | |
US29119001P | 2001-05-15 | 2001-05-15 | |
US29124001P | 2001-05-16 | 2001-05-16 | |
US29109901P | 2001-05-16 | 2001-05-16 | |
US29448501P | 2001-05-30 | 2001-05-30 | |
US29488901P | 2001-05-31 | 2001-05-31 | |
US29489901P | 2001-05-31 | 2001-05-31 | |
US29902701P | 2001-06-18 | 2001-06-18 | |
US29931001P | 2001-06-19 | 2001-06-19 | |
US29930301P | 2001-06-19 | 2001-06-19 | |
US30435401P | 2001-07-10 | 2001-07-10 | |
US30919801P | 2001-07-31 | 2001-07-31 | |
US31290301P | 2001-08-16 | 2001-08-16 | |
US31846201P | 2001-09-10 | 2001-09-10 | |
US31877001P | 2001-09-12 | 2001-09-12 | |
US32543001P | 2001-09-27 | 2001-09-27 | |
US32568101P | 2001-09-27 | 2001-09-27 | |
US33038001P | 2001-10-18 | 2001-10-18 | |
US33530101P | 2001-10-31 | 2001-10-31 | |
US33327201P | 2001-11-14 | 2001-11-14 | |
US33227201P | 2001-11-14 | 2001-11-14 | |
US33227101P | 2001-11-14 | 2001-11-14 | |
US33217201P | 2001-11-14 | 2001-11-14 | |
US33318401P | 2001-11-14 | 2001-11-14 | |
US33209401P | 2001-11-21 | 2001-11-21 | |
US33742601P | 2001-12-03 | 2001-12-03 | |
US33809201P | 2001-12-03 | 2001-12-03 | |
US33718501P | 2001-12-04 | 2001-12-04 | |
US34570502P | 2002-01-03 | 2002-01-03 | |
PCT/US2002/007288 WO2002072771A2 (en) | 2001-03-08 | 2002-03-08 | Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
US10/093,463 US20030208039A1 (en) | 2001-03-08 | 2002-03-08 | Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2005508604A JP2005508604A (ja) | 2005-04-07 |
JP2005508604A5 true JP2005508604A5 (enrdf_load_stackoverflow) | 2006-01-05 |
Family
ID=34468594
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2002571827A Pending JP2005508604A (ja) | 2001-03-08 | 2002-03-08 | 抗原性ポリペプチドに結合する新規抗体、抗原をコードする核酸、および使用方法 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2005508604A (enrdf_load_stackoverflow) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5002749B2 (ja) * | 2006-03-22 | 2012-08-15 | 富士フイルム株式会社 | 癌抑制剤 |
-
2002
- 2002-03-08 JP JP2002571827A patent/JP2005508604A/ja active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2003505075A5 (enrdf_load_stackoverflow) | ||
US7208470B2 (en) | Method of treating reproductive system cancer by administering follistatin-3 | |
KR970707141A (ko) | 종양 괴사 인자-감마(Tumor necrosis factor-gamma) | |
KR970701776A (ko) | 형질전환 성장 인자 알파 에이치1(Transforming growth factor alpha H1) | |
CA2195955A1 (en) | Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof | |
JP2005512515A5 (enrdf_load_stackoverflow) | ||
ATE419537T1 (de) | Verwendung eines polypeptids zur auffindung von multipler sklerose | |
EP2968451A1 (en) | Treatment of pediatric growth hormone deficiency with human growth hormone analogues | |
JP2000517174A (ja) | ケラチノサイト増殖因子―2(kgf―2または線維芽細胞増殖因子―12、fgf―12) | |
MX2008007324A (es) | Usos de antagonistas de miostatina. | |
HU230768B1 (hu) | Aß peptidet kiválasztó humanizált ellenanyagok | |
JP2007181465A (ja) | マクロファージ炎症蛋白変種をコードするポリヌクレオチド | |
PT92278B (pt) | Processo para a preparacao de proteinas de ligacao de factor de crescimento semelhante a insulina | |
WO2018195390A1 (en) | Methods of treating gastrointestinal motility -related disorders using variants and fusions of fgf19/fgf21 polypeptides | |
JP2002526073A (ja) | 新規のヒト生長分化因子のコード配列、そのdna配列によりコードされるポリペプチド、およびこれらの製造方法。 | |
KR970705635A (ko) | 사람 케모킨 베타-9(Human chemokine beta-9) | |
US20200062811A1 (en) | Yap protein inhibiting polypeptide and application thereof | |
JP2005507236A5 (enrdf_load_stackoverflow) | ||
JP2004533235A5 (enrdf_load_stackoverflow) | ||
JP2004537284A5 (enrdf_load_stackoverflow) | ||
JP2005528080A5 (enrdf_load_stackoverflow) | ||
JP2005508604A5 (enrdf_load_stackoverflow) | ||
JPWO2021229076A5 (enrdf_load_stackoverflow) | ||
JP2008502323A5 (enrdf_load_stackoverflow) | ||
WO2002030974A2 (en) | Proteins and nucleic acids encoding same |